NDC Package 55513-326-21 Riabni

Rituximab-arrx Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
55513-326-21
Package Description:
1 VIAL, SINGLE-DOSE in 1 CARTON / 50 mL in 1 VIAL, SINGLE-DOSE
Product Code:
Proprietary Name:
Riabni
Non-Proprietary Name:
Rituximab-arrx
Substance Name:
Rituximab
Usage Information:
Rituximab is used to treat certain types of cancer (such as non-Hodgkin's lymphoma, chronic lymphocytic leukemia). It works by slowing or stopping the growth of cancer cells. Some brands of rituximab are also used to treat rheumatoid arthritis and can decrease joint pain and swelling. This drug is also used to treat certain types of blood vessel disease (such as granulomatosis with polyangiitis, microscopic polyangiitis) and can decrease the swelling of the blood vessels. Rituximab is also used to treat a certain skin condition (pemphigus vulgaris). It helps to reduce the number of skin lesions. This monograph is about the following rituximab products: rituximab, rituximab-abbs, and rituximab-pvvr.
11-Digit NDC Billing Format:
55513032621
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Amgen, Inc
Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route(s):
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s):
Sample Package:
No
FDA Application Number:
BLA761140
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
01-06-2021
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
55513-326-011 VIAL, SINGLE-DOSE in 1 CARTON / 50 mL in 1 VIAL, SINGLE-DOSE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 55513-326-21?

The NDC Packaged Code 55513-326-21 is assigned to a package of 1 vial, single-dose in 1 carton / 50 ml in 1 vial, single-dose of Riabni, a human prescription drug labeled by Amgen, Inc. The product's dosage form is injection, solution and is administered via intravenous form.

Is NDC 55513-326 included in the NDC Directory?

Yes, Riabni with product code 55513-326 is active and included in the NDC Directory. The product was first marketed by Amgen, Inc on January 06, 2021 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 55513-326-21?

The 11-digit format is 55513032621. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-255513-326-215-4-255513-0326-21